Literature DB >> 16375887

Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity.

Saurabh Gupta1, Suneet Mehrotra, Carlos M Villalón, Ingrid M Garrelds, René de Vries, Jorge P van Kats, Hari S Sharma, Pramod R Saxena, Antoinette Maassenvandenbrink.   

Abstract

This study sets out to characterise calcitonin gene-related peptide (CGRP) receptors in human and porcine isolated proximal and distal coronary arteries using BIBN4096BS. Human (h)-alphaCGRP induced relaxations that were blocked by BIBN4096BS in all arteries studied. In contrast to the other vessels, the Schild plot slope in the human distal coronary artery segments (0.68 +/- 0.07) was significantly less than unity and BIBN4096BS potently blocked these responses (pK(b) (10 nM): 9.29 +/- 0.34, n = 5). In the same preparation, h-alphaCGRP(8-37) behaved as a weak antagonist of h-alphaCGRP-induced relaxations (pK(b) (3 microM): 6.28 +/- 0.17, n = 4), with also a Schild plot slope smaller than unity. The linear agonists, [ethylamide-Cys(2,7)]-h-alphaCGRP ([Cys(Et)(2,7)]-h-alphaCGRP) and [acetimidomethyl-Cys(2,7)]-h-alphaCGRP ([Cys(Acm)(2,7)]-h-alphaCGRP), had a high potency (pEC(50): 8.21 +/- 0.25 and 7.25 +/- 0.14, respectively), suggesting the presence of CGRP(2) receptors, while the potent blockade by BIBN4096BS (pK(b) (10 nM): 10.13 +/- 0.29 and 9.95 +/- 0.11, respectively) points to the presence of CGRP(1) receptors. Using RT-PCR, mRNAs encoding for the essential components for functional CGRP(1) receptors were demonstrated in both human proximal and distal coronary artery. Further, h-alphaCGRP (100 nM) increased cAMP levels, and this was attenuated by BIBN4096BS (1 microM). The above results demonstrate the presence of CGRP(1) receptors in all coronary artery segments investigated, but the human distal coronary artery segments seem to have an additional population of CGRP receptors not complying with the currently classified CGRP(1) or CGRP(2) receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16375887     DOI: 10.1016/j.ejphar.2005.11.020

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 2.  CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?

Authors:  C S Walker; D L Hay
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  AM₁-receptor-dependent protection by intermedin of human vascular and cardiac non-vascular cells from ischaemia-reperfusion injury.

Authors:  David Bell; Malcolm Campbell; Matthew Ferguson; Leah Sayers; Liz Donaghy; Anna O'Regan; Victoria Jewhurst; Mark Harbinson
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

4.  Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.

Authors:  Sajedeh Eftekhari; Lars Edvinsson
Journal:  Ther Adv Neurol Disord       Date:  2010-11       Impact factor: 6.570

5.  Effects of current and prospective antimigraine drugs on the porcine isolated meningeal artery.

Authors:  Suneet Mehrotra; Saurabh Gupta; Ingrid M Garrelds; Carlos M Villalón; Pramod R Saxena; Ad J J C Bogers; Antoinette Maassenvandenbrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-14       Impact factor: 3.000

6.  Depressed perivascular sensory innervation of mouse mesenteric arteries with advanced age.

Authors:  Erika M Boerman; Steven S Segal
Journal:  J Physiol       Date:  2015-06-30       Impact factor: 5.182

Review 7.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

8.  Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries.

Authors:  Saurabh Gupta; Jair Lozano-Cuenca; Carlos M Villalón; René de Vries; Ingrid M Garrelds; Cees J J Avezaat; Jorge P van Kats; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-02-13       Impact factor: 3.000

9.  Comment on "A second trigeminal CGRP receptor: function and expression of the AMY1 receptor".

Authors:  Kristian Agmund Haanes; Ka Yi Chan; Antoinette MaassenVanDenBrink
Journal:  Ann Clin Transl Neurol       Date:  2016-02-26       Impact factor: 4.511

Review 10.  Pharmacogenomics and migraine: possible implications.

Authors:  Peer Tfelt-Hansen; Kim Brøsen
Journal:  J Headache Pain       Date:  2008-01-24       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.